BioCardia, Inc.
BCDA
Rank in Stocks
#28408
BioCardia, Inc. is a pioneering clinical-stage company dedicated to... BioCardia, Inc. is a pioneering clinical-stage company dedicated to regenerative medicine, focusing on the development of advanced cellular and cell-derived therapies for a range of cardiac and respiratory ailments. Central to its pipeline is the CardiAMP Cell Therapy System, designed to address heart failure and chronic myocardial ischemia. Additionally, BioCardia is advancing an allogeneic cell therapy program, also targeting cardiac and pulmonary conditions. The company is further exploring a specific allogeneic cell therapeutic platform. This investigational treatment, derived from culture-expanded mesenchymal cells sourced from bone marrow, is currently undergoing Phase I/II trials for patients suffering from ischemic systolic heart failure. Beyond its therapeutic candidates, BioCardia also provides innovative delivery solutions. These include the Helix biotherapeutic delivery system, engineered to precisely administer treatments directly into the heart muscle via an internal penetrating helical needle, and a line of Morph deflectable guides and sheaths. BioCardia maintains its headquarters in Sunnyvale, California.
Share Price
$0.9217
Last synced: 2026-11-11
Market Cap
$11.15M
Change (1 day)
-0.91%
Change (1 year)
-29.10%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade BioCardia, Inc. (BCDA)
Category
Healthcare
Dividend yield history for BioCardia, Inc. (BCDA)
BioCardia, Inc. (stock symbol: BCDA) dividend yield (TTM) as of 2025: 0.00%
Average dividend yield, last 5 years : 0.00%
Average dividend yield, last 5 years : 0.00%
Dividend yield history for BioCardia, Inc. (BCDA) from 2001 to 2026
Dividend Yield at the end of each year (TTM)
| Year | Dividend Yield | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | 0.00% |
| 2018 | 0.00% | 0.00% |
| 2017 | 0.00% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | 0.00% |
| 2014 | 0.00% | 0.00% |
| 2013 | 0.00% | 0.00% |
| 2012 | 0.00% | 0.00% |
| 2011 | 0.00% | 0.00% |
| 2010 | 0.00% | 0.00% |
| 2009 | 0.00% | -100.00% |
| 2008 | 3.75% | 0.00% |
| 2007 | 0.00% | 0.00% |
| 2006 | 0.00% | 0.00% |
| 2005 | 0.00% | 0.00% |
| 2004 | 0.00% | 0.00% |
| 2003 | 0.00% | 0.00% |
| 2002 | 0.00% | 0.00% |
| 2001 | 0.00% | 0.00% |
Dividend yields (TTM) for similar companies or competitors
| Company | Dividend Yield | Country |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 2.02% |
AU
|
|
| 0.52% |
BE
|
|
| 0.00% |
NL
|
Questions about BioCardia, Inc.'s dividend yield
What was BioCardia, Inc.'s dividend yield in 2025?
In 2025, BioCardia, Inc.'s dividend yield was 0.00%, compared with 0.00% in 2024.
How has BioCardia, Inc.'s dividend yield changed since 2020?
From 2020 to 2025, BioCardia, Inc.'s dividend yield was highest in 2025 (0.00%) and lowest in 2025 (0.00%).
How does BioCardia, Inc.'s dividend yield compare with similar companies?
BioCardia, Inc.'s dividend yield (0.00%) is lower than that of all 5 similar companies listed above. The highest among them is CSL Limited, with 2.02%.